Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins
- PMID: 33917411
- PMCID: PMC8067509
- DOI: 10.3390/v13040625
Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins
Abstract
Vaccines and therapeutics targeting viral surface glycoproteins are a major component of disease prevention for respiratory viral diseases. Over the years, vaccines have proven to be the most successful intervention for preventing disease. Technological advances in vaccine platforms that focus on viral surface glycoproteins have provided solutions for current and emerging pathogens like SARS-CoV-2, and our understanding of the structural basis for antibody neutralization is guiding the selection of other vaccine targets for respiratory viruses like RSV. This review discusses the role of viral surface glycoproteins in disease intervention approaches.
Keywords: RSV; SARS-CoV-2; respiratory syncytial virus; respiratory virus; therapeutics; vaccines.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Wang X., Li Y., O’Brien K.L., Madhi S.A., Widdowson M.A., Byass P., Omer S.B., Abbas Q., Ali A., Amu A., et al. Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: A systematic review and modelling study. Lancet Glob. Health. 2020;8:e497–e510. doi: 10.1016/S2214-109X(19)30545-5. - DOI - PMC - PubMed
-
- Shi T., Arnott A., Semogas I., Falsey A.R., Openshaw P., Wedzicha J.A., Campbell H., Nair H., Investigators R. The etiological role of common respiratory viruses in acute respiratory infections in older adults: A systematic review and meta-analysis. J. Infect. Dis. 2020;222:S563–S569. doi: 10.1093/infdis/jiy662. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
